Skip to main content
Premium Trial:

Request an Annual Quote

Inpharmatica Wins Japanese Pharma Customer for Predictive ADME Software

NEW YORK, Oct. 11 (GenomeWeb News) - Inpharmatica has licensed its Admensa Interactive predictive ADME software to Japanese pharmaceutical company Mochida, the company said today.


This is the second Japanese company that has licensed Admensa Interactive, and the sixth overall since Inpharmatica launched the product in February.


The agreement was secured in conjunction with PharmaDesign, Inpharmatica's sales and marketing partner in Japan, Inpharmatica said.


Financial details of the agreement were not disclosed.

The Scan

Back as Director

A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports.

Research, But Implementation?

Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR.

For the False Negatives

The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results.

Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More

In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.